BICO Group AB (publ) (OTCMKTS:CLLKF – Get Free Report) saw a significant increase in short interest in January. As of January 15th, there was short interest totaling 11,371 shares, an increase of 74.5% from the December 31st total of 6,516 shares. Based on an average daily trading volume, of 1,975 shares, the short-interest ratio is presently 5.8 days. Based on an average daily trading volume, of 1,975 shares, the short-interest ratio is presently 5.8 days.
BICO Group AB (publ) Stock Performance
CLLKF opened at C$1.98 on Monday. The stock has a 50-day moving average of C$2.15 and a 200-day moving average of C$2.53. BICO Group AB has a 52-week low of C$1.88 and a 52-week high of C$4.21.
BICO Group AB (publ) Company Profile
BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.
In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.
Further Reading
- Five stocks we like better than BICO Group AB (publ)
- Trump just signed it
- A Message From An Ex-CIA Officer About Trump
- Buy this Gold Stock Before May 2026
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
